Cholangitis and multiple liver abscesses after percutaneous ethanol injection (PEI) for recurrent hepatocellular carcinoma (HCC)

被引:0
|
作者
Macias-Garcia, Fernando [1 ,3 ]
Vallejo-Senra, Nicolau [1 ,3 ]
Baleato-Gonzalez, Sandra [2 ]
Fernandez-Castroagudin, Javier [1 ,3 ]
Molina-Perez, Esther [1 ,3 ]
Enrique Dominguez-Munoz, J. [1 ,3 ]
机构
[1] Hosp Univ Santiago de Compostela, Dept Gastroenterol, Santiago De Compostela 15706, A Coruna, Spain
[2] Hosp Univ Santiago de Compostela, Dept Radiol, Santiago De Compostela 15706, A Coruna, Spain
[3] Fdn Res Digest Dis FIENAD, Santiago, Spain
关键词
Liver; Hepatocellular carcinoma (HCC); Percutaneous ethanol injection (PEI); Ablative percutaneous therapy; Cholangitis; NONCIRRHOTIC LIVER; ABLATION THERAPY; TUMORS;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Percutaneous ablation procedures are minimally invasive treatments for unresectable early stage hepatocellular carcinoma (HCC). These techniques are usually safe, but rare and even fatal complications have been described. We present a fatal result after percutaneous ethanol injection (PEI) for the treatment of a recurrent HCC in a non-cirrhotic liver, with subsequent development of diffuse cholangitis and multiple liver abscesses. Although percutaneous drainage and intensive antibiotic treatment were employed, the patient finally died. We discuss about the etiology and the physiopathology of this rare complication in which the therapeutic options are limited and usually unsuccessful.
引用
收藏
页码:110 / 112
页数:3
相关论文
共 50 条
  • [1] Prognostic factors for survival in cirrhotic patients with hepatocellular carcinoma (HCC) treated by percutaneous ethanol injection (PEI)
    Trombino, C
    Rapaccini, GL
    Pompili, M
    Caturelli, E
    Villani, MR
    Lorenzelli, GP
    Gasbarrini, G
    GUT, 1997, 41 : A184 - A184
  • [2] Colour Doppler US in evaluation of the response of hepatocellular carcinoma (HCC) to treatment with percutaneous ethanol injection (PEI)
    Eltaher, M.
    Moustafa, E. F. Abdou
    Nafeh, H. M.
    Mohamed, N. A.
    Mahran, M. M.
    LIVER INTERNATIONAL, 2006, 26 : 41 - 41
  • [3] Prognostic factors for survival in cirrhotic patients with hepatocellular carcinoma (HCC) treated with percutaneous ethanol injection (PEI)
    Universita Cattolica Sacro Cuore, Roma, Italy
    Ultrasound in Medicine and Biology, 1997, 23 (Suppl 1):
  • [4] Percutaneous ethanol injection (PEI) for patients with small hepatocellular carcinoma
    Ebara, M
    Saisho, H
    XV WORLD CONGRESS OF COLLEGIUM INTERNATIONALE CHIRURGIAE DIGESTIVAE (CICD), 1996, : 305 - 308
  • [5] Multiple intrahepatic implantations of hepatocellular carcinoma following percutaneous ethanol injection (PEI) therapy
    Petsas, T
    Kalogeropoulou, C
    Tsota, I
    Tsamandas, AC
    LIVER INTERNATIONAL, 2006, 26 (03) : 382 - 384
  • [6] ANGIOGRAPHIC FOLLOW-UP AFTER PERCUTANEOUS ETHANOL INJECTION (PEI) FOR HEPATOCELLULAR-CARCINOMA (HCC) IN CIRRHOTIC-PATIENTS
    MARIN, G
    ROSSARO, L
    MIOLA, E
    ERNE, E
    ROSATI, M
    RIZZI, M
    DONA, S
    PACCAGNELLA, D
    RAGAZZI, R
    PERINI, L
    GASTROENTEROLOGY, 1994, 106 (04) : A939 - A939
  • [7] Percutaneous ethanol injection therapy (PEIT) for hepatocellular carcinoma (HCC)
    Mueller, PR
    JAPANESE JOURNAL OF CANCER RESEARCH, 1995, 86 (12): : 1244 - 1245
  • [8] Is tumor size the only factor that determines the efficacy of percutaneous ethanol injection (PEI) for the treatment of hepatocellular carcinoma (HCC)?
    Di Costanzo, GG
    de Luca, M
    Ascione, A
    JOURNAL OF HEPATOLOGY, 2002, 36 : 78 - 78
  • [9] Comparison between percutaneous ethanol injection (PEI) and transarterial chemoembolization (TACE) in patients with small hepatocellular carcinoma (HCC)
    Cioni, G
    Turrini, E
    Baraldi, E
    Pedrazzini, PG
    Ventura, E
    Ferrari, A
    D'Alimonte, P
    Ariosi, P
    De Santis, M
    JOURNAL OF HEPATOLOGY, 2000, 32 : 167 - 167
  • [10] Efficacy of transarterial chemoembolization (TACE) associated to percutaneous ethanol injection (PEI) in the treatment of small hepatocellular carcinoma (HCC).
    Bolondi, L
    Sofia, S
    Venturoli, N
    Casali, A
    Siringo, S
    Livraghi, T
    GASTROENTEROLOGY, 1996, 110 (04) : A1153 - A1153